,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,54893,10,5,,103188207,4887,Unspecified,123779610.0,100135514.0,214.0,Kd,Dissociation constant for CysLT1 receptor was determined by the displacement of [3H]LTD4 from guinea pig lung membranes,Confirmatory,,
1,54897,8,5,,103188207,4887,Active,123779610.0,100135514.0,0.001,IC50,Binding affinity towards Cysteinyl leukotriene D4 receptor (cysLT1) was measured by the displacement of [3H]LTD4 radioligand,Confirmatory,9554877.0,
2,55061,12,1,,103188207,4887,Active,,,0.001,Kd,Displacement of [3H]LTD4 from Cysteinyl leukotriene D4 receptor in guinea pig lung membranes,Confirmatory,9089329.0,
3,55238,8,5,,103188207,4887,Active,123779610.0,100135514.0,0.0008,Ki,In vitro binding of Cysteinyl leukotriene receptor 1 to guinea pig lung membranes,Confirmatory,10509933.0,
4,55239,7,6,,103188207,4887,Active,123779610.0,100135514.0,0.0008,Ki,Antagonism of Cysteinyl leukotriene receptor 1 from guinea pig lung membranes,Confirmatory,9934474.0,
5,76101,3,3,,103188207,4887,Unspecified,,,,,Inhibition of LTD4 (5 ng/site) induced vascular permeability in guinea pig skin at dose 0.3 mg/kg given perorally,Other,3336036.0,
6,76103,3,3,,103188207,4887,Unspecified,,,,,Inhibition of LTD4 (5 ng/site) induced vascular permeability in guinea pig skin at dose 1 mg/kg given perorally,Other,3336036.0,
7,76117,3,3,,103188207,4887,Unspecified,,,,,Inhibition of LTD4 induced increase of vascular permeability after injection of 10 ng/site at 1 uM intraperitoneally,Other,9089329.0,
8,76641,6,2,,103188207,4887,Unspecified,,,,,Compound was evaluated in vivo for antigen induced airway obstruction in guinea pig (OA) at 1.0 hour after oral administration,Other,10509933.0,
9,76645,5,2,,103188207,4887,Inconclusive,,,,,Compound was evaluated in vivo for cysLT1 receptor induced airway obstruction in guinea pig (OA) at 1.0 hour after oral administration; NT means not tested,Other,10509933.0,
10,76653,6,2,,103188207,4887,Unspecified,,,,,Compound was tested for antigen induced airway obstruction in guinea pig at 1.0 hr upon peroral administration,Other,9873435.0,
11,76829,6,4,,103188207,4887,Unspecified,,,,,In vivo inhibition of LTD4-induced bronchoconstriction in anesthetized guinea pig.,Other,3336036.0,
12,76846,6,2,,103188207,4887,Unspecified,,,,,Inhibition of LTB4 induced bronchoconstriction in guinea pig at dose of 3 ug/kg given intravenously,Other,3336036.0,
13,76848,6,2,,103188207,4887,Unspecified,,,,,Inhibition of LTC4-induced bronchoconstriction in guinea pig at dose of (0.5 ug/kg) given intravenously,Other,3336036.0,
14,76851,6,2,,103188207,4887,Unspecified,,,,,Inhibition of LTD4-induced bronchoconstriction in guinea pig in guinea pig at dose of (0.5 ug/kg) given intravenously,Other,3336036.0,
15,76853,6,2,,103188207,4887,Unspecified,,,,,Inhibition of LTE4-induced bronchoconstriction in guinea pig at dose of (1 ug/kg) given intravenously,Other,3336036.0,
16,78036,3,3,,103188207,4887,Unspecified,,,,,Compound was tested for its ability to block antigen induced airway obstruction in guinea pig at dose 1 mg/kg at 1 hr,Other,9934474.0,
17,78302,4,6,,103188207,4887,Active,,,4.4e-05,IC50,Inhibition of LTC4 induced smooth muscle contraction of guinea pig ileum,Confirmatory,3336036.0,
18,79839,3,4,,103188207,4887,Unspecified,,,,,Antagonistic activity against LTD4 induced contraction in guinea pig trachea,Other,1849993.0,
19,79846,3,4,,103188207,4887,Unspecified,,,,,Compound was tested for LTD4 guinea pig trachea contraction,Other,8709092.0,
20,80467,3,4,,103188207,4887,Unspecified,,,,,Inhibition of ovalbumin-induced contraction (10 ng/mL) of guinea pig trachea at 10 uM.,Other,9089329.0,
21,88878,3,4,,103188207,4887,Unspecified,,,,,Fold shift in LTD4 dose response curve 24 hr following 450 mg oral dose,Other,8709092.0,
22,88879,3,4,,103188207,4887,Unspecified,,,,,Fold shift in LTD4 dose response curve 3-5 hr after 5 days 450 mg bid,Other,8709092.0,
23,88880,3,3,,103188207,4887,Unspecified,,,,,Fold shift in LTD4 dose response curve 3.5 hours after 5 days of 450 mg bid,Other,8709092.0,
24,101446,9,1,,103188207,4887,Active,,,0.0008,Ki,Ability to antagonize LTD4 receptors isolated from guinea pig lung membranes,Confirmatory,9873435.0,
25,214417,4,4,,103188207,4887,Active,,,0.001,IC50,In vitro blocking of extracellular calcium mobilization in human U937 cells,Confirmatory,10509933.0,
26,214564,6,2,,103188207,4887,Active,,,0.001,IC50,Compound was evaluated for influx of calcium mobilization in human U937 cells,Confirmatory,9873435.0,
27,221984,6,2,,103188207,4887,Active,,,0.001,IC50,Compound was tested for its ability to inhibit calcium influx in human U937 cells,Confirmatory,9934474.0,
28,428078,6,2,,103188207,4887,Unspecified,,,,,Inhibition of LTD4-induced airway microvascular permeability in po dosed Dunkin-Hartley guinea pig after 1 hr using Evans blue staining,Other,19505824.0,
29,428079,6,2,,103188207,4887,Unspecified,,,,,Inhibition of LTD4-induced airway microvascular permeability in po dosed Dunkin-Hartley guinea pig after 4 hrs using Evans blue staining,Other,19505824.0,
30,428080,6,2,,103188207,4887,Unspecified,,,,,Inhibition of LTD4-induced airway microvascular permeability in po dosed Dunkin-Hartley guinea pig after 8 hrs using Evans blue staining,Other,19505824.0,
31,484274,8,5,,103188207,4887,Active,118157.0,,7.0,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,Confirmatory,20426472.0,
32,484275,8,5,,103188207,4887,Unspecified,118157.0,,68.0,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in presence of 0.01% Triton X-100,Confirmatory,20426472.0,
33,484276,3,3,,103188207,4887,Unspecified,,,,,Colloidal aggregation in fed state simulated intestinal fluid by dynamic light scattering assay in presence of 1% DMSO,Other,20426472.0,
34,484380,3,3,,103188207,4887,Unspecified,,,,,Colloidal aggregation in fed state simulated intestinal fluid assessed as colloid radius at 50 uM by dynamic light scattering assay in presence of 1% DMSO,Other,20426472.0,
35,497575,5,6,,103188207,4887,Active,20138087.0,10800.0,0.0008,IC50,Antagonist activity at CysLT1 receptor in human dU937 cells assessed as inhibition of LTD4-induced increase of calcium level treated 30 mins before LTD4 challenge,Confirmatory,20621485.0,
36,602332,1,1,,50126316,4887,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
37,624030,1,2,,50126316,4887,Inconclusive,160794.0,,11.4239,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
38,624170,1,1,,50126316,4887,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
39,624172,1,1,,50126316,4887,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
40,624173,1,3,,50126316,4887,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
41,624349,1,2,,92308832,4887,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
42,651631,4,1,,144206505,4887,Inconclusive,269849759.0,7157.0,1.3333,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
43,651632,4,1,,144206505,4887,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
44,651633,4,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
45,651634,4,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
46,651828,1,2,,92308832,4887,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
47,652048,1,2,,144206505,4887,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
48,652051,1,1,,144206505,4887,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
49,680424,1,7,,103188207,4887,Unspecified,74761045.0,,,,"TP_TRANSPORTER: inhibition of MTX uptake (MTX: 1 uM, ONO-1078: 33 uM) in membrane vesicles from MRP3-expressing HEK293 cells",Other,11585759.0,
50,681102,1,8,,103188207,4887,Unspecified,296439301.0,4363.0,,,"TP_TRANSPORTER: inhibition of LTC4 uptake (LTC4: 0.00134 uM, ONO-1078: 100 uM) in membrane vesicles from CV60 cells",Other,9751271.0,
51,681175,3,6,,103188207,4887,Unspecified,3219824.0,25303.0,41.1,Ki,TP_TRANSPORTER: inhibition of DNP-SG uptake in bile canalicular membrane vesicles from SD rat,Confirmatory,15618649.0,
52,686978,1,1,,144206505,4887,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
53,686979,1,1,,144206505,4887,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
54,720516,2,1,,144206505,4887,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
55,720532,1,1,,144206505,4887,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
56,720533,1,1,,144206505,4887,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
57,720552,2,1,,144206505,4887,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
58,720634,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
59,720635,2,1,,144206505,4887,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
60,720637,2,1,,144206505,4887,Inconclusive,,,11.0053,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
61,720641,1,2,,92308832,4887,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
62,720674,2,2,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
63,720675,2,2,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
64,720678,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
65,720679,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
66,720680,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
67,720681,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
68,720682,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
69,720683,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
70,720684,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
71,720685,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
72,720686,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
73,720687,2,2,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
74,720691,4,1,,144206505,4887,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
75,720692,3,1,,144206505,4887,Inconclusive,311348376.0,2908.0,7.5624,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
76,720693,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
77,720717,1,3,,92308832,4887,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
78,720719,2,1,,144206505,4887,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
79,720725,2,1,,144206505,4887,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
80,743012,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
81,743014,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
82,743015,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
83,743033,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
84,743035,2,1,,144206505,4887,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
85,743036,2,1,,144206505,4887,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
86,743040,3,1,,144206505,4887,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
87,743041,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
88,743042,3,1,,144206505,4887,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
89,743053,2,1,,144206505,4887,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
90,743054,2,1,,144206505,4887,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
91,743063,2,1,,144206505,4887,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
92,743064,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
93,743065,3,1,,144206505,4887,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
94,743066,3,1,,144206505,4887,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
95,743067,2,1,,144206505,4887,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
96,743069,2,1,,144206505,4887,Inconclusive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
97,743074,2,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
98,743075,2,1,,144206505,4887,Inactive,348019627.0,2099.0,8.4852,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
99,743077,2,1,,144206505,4887,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
100,743078,2,1,,144206505,4887,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
101,743079,3,1,,144206505,4887,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
102,743080,3,1,,144206505,4887,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
103,743081,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
104,743083,3,1,,144206505,4887,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
105,743084,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
106,743085,3,1,,144206505,4887,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
107,743086,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
108,743091,2,1,,144206505,4887,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
109,743094,3,1,,144206505,4887,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
110,743122,2,1,,144206505,4887,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
111,743139,2,1,,144206505,4887,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
112,743140,2,1,,144206505,4887,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
113,743191,3,1,,144206505,4887,Inconclusive,216409692.0,5468.0,5.3076,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
114,743194,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
115,743199,2,1,,144206505,4887,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
116,743202,4,1,,144206505,4887,Inconclusive,20149576.0,4780.0,5.9553,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
117,743203,3,1,,144206505,4887,Active,,,29.846999999999998,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
118,743209,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
119,743210,4,1,,144206505,4887,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
120,743211,3,1,,144206505,4887,Inconclusive,,,33.4889,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
121,743212,3,1,,144206505,4887,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
122,743213,3,1,,144206505,4887,Inconclusive,,,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
123,743215,3,1,,144206505,4887,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
124,743217,3,1,,144206505,4887,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
125,743218,3,1,,144206505,4887,Inconclusive,,,6.6819,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
126,743219,3,1,,144206505,4887,Inconclusive,20149576.0,4780.0,11.0044,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
127,743220,3,1,,144206505,4887,Inconclusive,325495553.0,9971.0,2.6601,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
128,743221,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
129,743222,3,1,,144206505,4887,Inconclusive,216409708.0,7421.0,10.5901,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
130,743223,3,1,,144206505,4887,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
131,743224,3,1,,144206505,4887,Inconclusive,,,42.16,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
132,743225,3,1,,144206505,4887,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
133,743226,2,1,,144206505,4887,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
134,743227,2,1,,144206505,4887,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
135,743228,3,1,,144206505,4887,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
136,743239,2,1,,144206505,4887,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
137,743240,2,1,,144206505,4887,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
138,743241,2,1,,144206505,4887,Inconclusive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
139,743242,2,1,,144206505,4887,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
140,743244,1,1,,144206505,4887,Inactive,,,15.8489,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
141,743344,1,1,,50126316,4887,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
142,743345,1,1,,50126316,4887,Inactive,,,8.4071,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
143,743346,1,1,,50126316,4887,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
144,743347,1,1,,50126316,4887,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
145,1079931,1,1,,103188207,4887,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
146,1079932,1,1,,103188207,4887,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
147,1079933,1,1,,103188207,4887,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
148,1079934,1,1,,103188207,4887,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
149,1079935,1,1,,103188207,4887,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
150,1079936,1,1,,103188207,4887,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
151,1079937,1,1,,103188207,4887,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
152,1079938,1,1,,103188207,4887,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
153,1079939,1,1,,103188207,4887,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
154,1079940,1,1,,103188207,4887,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
155,1079941,1,1,,103188207,4887,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
156,1079942,1,1,,103188207,4887,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
157,1079943,1,1,,103188207,4887,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
158,1079944,1,1,,103188207,4887,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
159,1079945,1,1,,103188207,4887,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
160,1079946,1,1,,103188207,4887,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
161,1079947,1,1,,103188207,4887,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
162,1079948,1,1,,103188207,4887,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
163,1079949,1,1,,103188207,4887,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
164,1117298,1,2,,50126316,4887,Unspecified,,,,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
165,1117304,1,2,,50126316,4887,Inactive,,,15.8489,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
166,1117305,1,2,,50126316,4887,Inactive,,,35.4813,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
167,1117310,1,1,,50126316,4887,Inactive,,,,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
168,1117312,1,1,,50126316,4887,Inactive,,,35.4813,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
169,1117314,1,1,,50126316,4887,Inactive,,,15.8489,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
170,1117326,1,1,,50126316,4887,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
171,1117329,1,1,,50126316,4887,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
172,1117336,1,1,,50126316,4887,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
173,1117340,1,1,,50126316,4887,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
174,1117341,1,1,,50126316,4887,Active,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
175,1117342,1,1,,50126316,4887,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
176,1117343,1,1,,50126316,4887,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
177,1117344,1,1,,50126316,4887,Inactive,,,40.0,IC50,GLP1 secretion from NCI-H716 cells-IC50,Confirmatory,,
178,1117345,1,1,,50126316,4887,Inactive,,,40.0,IC50,GLP1 secretion from STC-1 cells-IC50,Confirmatory,,
179,1117346,1,1,,50126316,4887,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
180,1137667,1,3,,103188207,4887,Active,21264435.0,2840.0,4.06,Ki,Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay,Confirmatory,24900835.0,
181,1159509,1,1,,144206505,4887,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
182,1159515,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
183,1159516,1,1,,144206505,4887,Inconclusive,119611100.0,22926.0,30.1065,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
184,1159517,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
185,1159518,1,1,,144206505,4887,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
186,1159519,1,1,,144206505,4887,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
187,1159520,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
188,1159521,1,1,,144206505,4887,Inconclusive,15928672.0,19885.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
189,1159523,1,1,,144206505,4887,Inconclusive,15928672.0,19885.0,15.8465,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
190,1159525,1,1,,144206505,4887,Inconclusive,,,16.9301,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
191,1159526,1,1,,144206505,4887,Inconclusive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
192,1159527,1,1,,144206505,4887,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
193,1159528,1,1,,144206505,4887,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
194,1159529,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
195,1159531,1,1,,144206505,4887,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
196,1159551,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
197,1159552,1,1,,144206505,4887,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
198,1159553,2,1,,144206505,4887,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
199,1159555,1,1,,144206505,4887,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
200,1159614,1,2,,50126316,4887,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
201,1159620,1,1,,103188207,4887,Active,,,,,Summary of drug indications.,Other,,
202,1224824,1,1,,50126316,4887,Inactive,,,18.6548,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
203,1224825,1,1,,50126316,4887,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
204,1224834,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
205,1224835,1,1,,144206505,4887,Active,160794.0,,27.5404,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
206,1224836,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
207,1224837,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
208,1224838,1,1,,144206505,4887,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
209,1224839,1,1,,144206505,4887,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
210,1224840,3,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
211,1224841,3,1,,144206505,4887,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
212,1224842,3,1,,144206505,4887,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
213,1224843,1,1,,144206505,4887,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
214,1224844,1,1,,144206505,4887,Active,,,5.3538,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
215,1224845,1,1,,144206505,4887,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
216,1224846,1,1,,144206505,4887,Inconclusive,11995455.0,3091.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
217,1224847,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
218,1224848,3,1,,144206505,4887,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
219,1224849,3,1,,144206505,4887,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
220,1224857,2,1,,50126316,4887,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
221,1224859,2,1,,50126316,4887,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
222,1224863,1,1,,176484201,4887,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
223,1224867,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
224,1224868,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
225,1224869,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
226,1224870,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
227,1224871,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
228,1224872,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
229,1224873,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
230,1224874,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
231,1224875,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
232,1224876,1,1,,144206505,4887,Inconclusive,,,23.9145,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
233,1224877,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
234,1224878,1,1,,144206505,4887,Inconclusive,,,23.9145,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
235,1224879,1,1,,144206505,4887,Inconclusive,,,26.8325,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
236,1224880,1,1,,144206505,4887,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
237,1224881,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
238,1224882,1,1,,144206505,4887,Active,,,26.8325,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
239,1224883,1,1,,144206505,4887,Inconclusive,,,26.8325,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
240,1224884,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
241,1224885,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
242,1224886,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
243,1224887,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
244,1224888,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
245,1224889,1,1,,144206505,4887,Inconclusive,,,23.9145,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
246,1224890,1,1,,144206505,4887,Active,,,21.3138,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
247,1224892,1,1,,144206505,4887,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
248,1224893,1,1,,144206505,4887,Inconclusive,66775687.0,9970.0,8.91116,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
249,1224894,1,1,,144206505,4887,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
250,1224895,1,1,,144206505,4887,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
251,1224896,1,1,,144206505,4887,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
252,1224905,2,1,,92308832,4887,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
253,1224905,2,1,,92308832,4887,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
254,1236111,1,1,,103188207,4887,Active,20138034.0,57105.0,3.62,IC50,Antagonist activity at human CysLT2 expressed in HEK293T cells assessed as inhibition of LTC4-induced effect preincubated for 30 mins prior to LTC4 addition by Aequorin luminescence assay,Confirmatory,26200813.0,
255,1236112,1,1,,103188207,4887,Active,20138087.0,10800.0,0.0043,IC50,Antagonist activity at human CysLT1,Confirmatory,26200813.0,
256,1259241,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
257,1259242,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
258,1259243,1,1,,144206505,4887,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
259,1259244,1,1,,144206505,4887,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
260,1259247,1,1,,144206505,4887,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
261,1259248,1,1,,144206505,4887,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
262,1259252,1,1,,50126316,4887,Active,169655958.0,,16.6261,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
263,1259253,1,1,,50126316,4887,Active,169655958.0,,18.6548,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
264,1259255,1,1,,50126316,4887,Inconclusive,169655958.0,,18.6548,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
265,1259256,1,1,,50126316,4887,Active,169655958.0,,18.6548,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
266,1259310,1,1,,333493974,4887,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
267,1259310,1,1,,333494242,4887,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
268,1259325,1,2,,336956104,4887,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
269,1259344,1,1,,144206505,4887,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
270,1259364,1,1,,144206505,4887,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
271,1259365,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
272,1259366,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
273,1259367,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
274,1259368,1,1,,144206505,4887,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
275,1259369,1,1,,144206505,4887,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
276,1259377,1,1,,144206505,4887,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
277,1259378,1,1,,144206505,4887,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
278,1259379,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
279,1259380,1,1,,144206505,4887,Active,,,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
280,1259381,1,1,,144206505,4887,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
281,1259382,1,1,,144206505,4887,Inconclusive,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
282,1259383,1,1,,144206505,4887,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
283,1259384,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
284,1259385,1,1,,144206505,4887,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
285,1259386,1,1,,144206505,4887,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
286,1259387,1,1,,144206505,4887,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
287,1259388,1,1,,144206505,4887,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
288,1259390,1,1,,144206505,4887,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
289,1259391,1,1,,144206505,4887,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
290,1259392,1,1,,144206505,4887,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
291,1259393,1,1,,144206505,4887,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
292,1259394,1,1,,144206505,4887,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
293,1259395,1,1,,144206505,4887,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
294,1259396,1,1,,144206505,4887,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
295,1259400,1,1,,50126316,4887,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
296,1259401,1,1,,144206505,4887,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
297,1259402,1,1,,144206505,4887,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
298,1259403,1,1,,144206505,4887,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
299,1259404,1,1,,144206505,4887,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
300,1259416,1,2,,340080454,4887,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
301,1259416,1,2,,375162905,4887,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
302,1259421,1,1,,340080454,4887,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
303,1259421,1,1,,375162905,4887,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
